These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17015282)

  • 1. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder.
    Chovanová Z; Muchová J; Sivonová M; Dvoráková M; Zitnanová I; Waczulíková I; Trebatická J; Skodácek I; Duracková Z
    Free Radic Res; 2006 Sep; 40(9):1003-10. PubMed ID: 17015282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD).
    Dvoráková M; Sivonová M; Trebatická J; Skodácek I; Waczuliková I; Muchová J; Duracková Z
    Redox Rep; 2006; 11(4):163-72. PubMed ID: 16984739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does pycnogenol® influence oxidative damage to DNA and its repair ability in elderly people?
    Dvořáková M; Paduchová Z; Muchová J; Duračková Z; Collins AR
    Prague Med Rep; 2010; 111(4):263-71. PubMed ID: 21189165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol).
    Dvoráková M; Jezová D; Blazícek P; Trebatická J; Skodácek I; Suba J; Iveta W; Rohdewald P; Duracková Z
    Nutr Neurosci; 2007; 10(3-4):151-7. PubMed ID: 18019397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Pycnogenol on DNA damage in vitro and expression of superoxide dismutase and HP1 in Escherichia coli SOD and catalase deficient mutant cells.
    Kim YG; Park HY
    Phytother Res; 2004 Nov; 18(11):900-5. PubMed ID: 15597332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis.
    Cisár P; Jány R; Waczulíková I; Sumegová K; Muchová J; Vojtassák J; Duraćková Z; Lisý M; Rohdewald P
    Phytother Res; 2008 Aug; 22(8):1087-92. PubMed ID: 18570266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ADHD with French maritime pine bark extract, Pycnogenol.
    Trebatická J; Kopasová S; Hradecná Z; Cinovský K; Skodácek I; Suba J; Muchová J; Zitnanová I; Waczulíková I; Rohdewald P; Duracková Z
    Eur Child Adolesc Psychiatry; 2006 Sep; 15(6):329-35. PubMed ID: 16699814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bach flower remedies used for attention deficit hyperactivity disorder in children--a prospective double blind controlled study.
    Pintov S; Hochman M; Livne A; Heyman E; Lahat E
    Eur J Paediatr Neurol; 2005; 9(6):395-8. PubMed ID: 16257245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
    Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial.
    Amiri S; Mohammadi MR; Mohammadi M; Nouroozinejad GH; Kahbazi M; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):145-9. PubMed ID: 17765380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW; Earl CQ; Arora S
    Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pycnogenol does not impact the antioxidant or vitamin C status of healthy young adults.
    Silliman K; Parry J; Kirk LL; Prior RL
    J Am Diet Assoc; 2003 Jan; 103(1):67-72. PubMed ID: 12525796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iron supplementation on attention deficit hyperactivity disorder in children.
    Konofal E; Lecendreux M; Deron J; Marchand M; Cortese S; Zaïm M; Mouren MC; Arnulf I
    Pediatr Neurol; 2008 Jan; 38(1):20-6. PubMed ID: 18054688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.
    Yang HM; Liao MF; Zhu SY; Liao MN; Rohdewald P
    Acta Obstet Gynecol Scand; 2007; 86(8):978-85. PubMed ID: 17653885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.